{"id":331256,"date":"2026-10-28T22:10:07","date_gmt":"2026-10-28T16:40:07","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/aarti-pharmalabs-q2-results-fy27-pat-71-crore\/"},"modified":"2026-10-28T22:10:07","modified_gmt":"2026-10-28T16:40:07","slug":"aarti-pharmalabs-q2-results-fy27-pat-71-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/aarti-pharmalabs-q2-results-fy27-pat-71-crore\/","title":{"rendered":"Aarti Pharmalabs Q2 Results FY27: PAT Jumps 155.98% to Rs 71.47 Cr, Revenue Rs 610.45 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Aarti Pharmalabs Q2 Results FY27 were declared on 28 October 2026, and the quarterly results show consolidated revenue of Rs 610.45 Cr, up 45.93% from Rs 418.33 Cr a year earlier. Net profit stood at Rs 71.47 Cr against Rs 27.92 Cr, a YoY growth of 155.98%. Operating Profit rose 80.89% to Rs 135.16 Cr. All figures are consolidated results for the July to September 2026 quarter.<\/p>\n<\/div>\n

Aarti Pharmalabs Ltd<\/a> (AARTIPHARM) Q2 Results FY27 announced on 28 October 2026, covering the company’s financial performance for the July to September quarter. The company reported revenue of Rs 610.45 Cr and net profit of Rs 71.47 Cr on a Consolidated basis. The results date falls on the day the board met, and Aarti Pharmalabs Q2 Results FY27 are the consolidated results that investors on NSE and BSE can now compare with the same quarter last year.<\/p>\n

This Aarti Pharmalabs Q2 Results results analysis covers the financial highlights, the business factors named in the disclosures, the FY27 outlook and the risks to track. Each section picks up from the one before it, starting with the Financial Highlights table that sets the revenue, Operating Profit and net profit side by side.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n